Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
06 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-data-publication-of-two-phase-1-studies-of-first-in-class-neutrophil-modulator-ads051-in-the-american-journal-of-gastroenterology-302393958.html
22 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-positive-topline-data-from-phase-1b-study-of-ads051-for-the-treatment-of-moderate-to-severe-ulcerative-colitis-301963581.html
12 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adiso-therapeutics-expands-board-of-directors-with-appointment-of-robert-lisicki-301953998.html
07 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adiso-therapeutics-to-participate-in-upcoming-september-investor-conferences-301920146.html
13 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-publication-of-compelling-preclinical-research-on-ads051-a-first-in-class-oral-gut-restricted-small-molecule-modulator-of-neutrophil-trafficking-and-activation-301876623.html
06 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-publication-in-journal-of-clinical--translational-immunology-highlighting-the-ads032-mechanism-of-action-301870347.html
ABOUT THIS PAGE